Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Brincidofovir

EU orphan designation number: EU/3/16/1777   
Active ingredient: Brincidofovir
Indication: Treatment of smallpox
Sponsor: Chimerix UK Ltd
5th Floor, 6 St Andrew Street, London EC4A 3AE, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/11/2016 Orphan designation EMA/OD/180/16 (2016)7619 of 18/11/2016